Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4459-4465

  Kuramitsu, Yasuhiro ^a   Baron, Byron ^a   Yoshino, Shigefumi ^a   Zhang, Xiulian ^a   Tanaka, Toshiyuki ^a   Yashiro, Masakazu ^b   Hirakawa, Kosei ^b   Oka, Masaaki ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

14 3 3 sigma protein; Gastric carcinoma cells; LC MS MS; Peptide sequence tag

Indexed keywords

ALPHA TROPOMYOSIN; DJ 1 PROTEIN; ELONGATION FACTOR 1BETA; ELONGATION FACTOR TU; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 1; PROTEIN 14 3 3;

AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

14-3-3 PROTEINS; ADENOCARCINOMA, SCIRRHOUS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXONUCLEASES; GASTRIC MUCOSA; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 78650239590     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nakazawa K, Yashiro M and Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852, 2003. (Pubitemid 38064064)
2. Otsuji E, Kuriu Y, Okamoto K, Ochiai T, Ichikawa D, Hagiwara A and Yamagishi H: Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg 188: 327-332, 2004.
3. Nakata B, Mitachi Y, Tsuji A, Yamamitsu S, Hirata K, Shirasaka T and Hirakawa K: Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902). Clin Cancer Res 10: 1664-1669, 2004.
4. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL and Humphery-Smith I: Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16: 1090-1094, 1995.
5. Anderson NL and Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19: 1853-1861, 1998.
6. Kuramitsu Y and Nakamura K: Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 6: 5650-5661, 2006. (Pubitemid 44683228)
7. Kuramitsu Y and Nakamura K: Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Rev Proteomics 2: 589-601, 2005. (Pubitemid 41139841)
8. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuriya K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K and Sakaida I: Proteomics finding heat-shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
9. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuriya K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K and Sakaida I: Proteomics finding heat-shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
10. Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Down-regulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 29: 2651-2659, 2008.
11. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6: 3894-3900, 2006.
12. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Sakaida I, Okita K, Oka M, and Nakamura K: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686-1692, 2005.
13. Kuramitsu Y, Harada T, Takashima M, Yokoyama Y, Hidaka I, Iizuka N, Toda T, Fujimoto M, Zhang X, Sakaida I, Okita K, Oka M and Nakamura K: Increased expression, and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues of patients infected with hepatitis C virus. Electrophoresis 27: 1651-1658, 2006.
14. Moreira JM, Ohlsson G, Rank FE and Celis JE: Down-regulation of the tumor suppressor protein 14-3-3 sigma is a sporadic event in cancer of the breast. Mol Cell Proteomics 4: 555-569, 2005.
15. Moreira JM, Gromov P and Celis JE: Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics 3: 410-419, 2004.
16. Liu Y, Chen Q and Zhang JT: Tumor suppressor gene 14-3-3 sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J Proteome Res 3: 728-735, 2004.
17. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T and Imai K: Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19: 5298-5302, 2000.
18. Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M and Takahashi T: Frequent and histological type-specific inactivation of 14-3-3 sigma in human lung cancers. Oncogene 21: 2418-2424, 2002.
19. Mhawach P, Greloz V, Assaly M and Herrmann F: Immunohistochemical expression of 14-3-3 sigma protein in human urological and gynecological tumors using a multi-tumor microarray analysis. Pathol Int 55: 77-82, 2005.
20. Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM and Eble JN: Loss of 14-3-3 sigma in prostate cancer and its precursors. Clin Cancer Res 10: 3064-3068, 2004.
21. Qi W, Liu X, Qiao D and Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363, 2005.
22. Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA and Reed SG: Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110: 374-381, 2000.
23. Hayashi E, Kuramitsu Y, Fujimoto M, Zhang X, Tanaka T, Uchida K, Fukuda T, Furumoto H, Ueyama Y and Nakamura K: Proteomic profiling of differential display analysis for human oral squamous cell carcinoma: 14-3-3 σ protein is up-regulated in human OSCC and dependent on the differentiation level. Proteomics Clin Appl 3: 1338-1347, 2009.